AVBP Annual Cash & Cash Equivalents
$150.39 M
-$12.98 M-7.95%
31 December 2023
Summary:
As of January 23, 2025, AVBP annual cash & cash equivalents is $150.39 million, with the most recent change of -$12.98 million (-7.95%) on December 31, 2023. During the last 3 years, it has risen by +$113.11 million (+303.40%). AVBP annual cash & cash equivalents is now -7.95% below its all-time high of $163.37 million, reached on December 31, 2022.AVBP Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVBP Quarterly Cash And Cash Equivalents
$150.39 M
-$148.28 M-49.65%
01 September 2024
Summary:
As of January 23, 2025, AVBP quarterly cash and cash equivalents is $150.39 million, with the most recent change of -$148.28 million (-49.65%) on September 1, 2024. Over the past year, it has dropped by -$148.28 million (-49.65%). AVBP quarterly cash and cash equivalents is now -52.62% below its all-time high of $317.39 million, reached on March 31, 2024.AVBP Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
AVBP Cash And Cash Equivalents Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -8.0% | -49.6% |
| 3 y3 years | +303.4% | -49.6% |
| 5 y5 years | +303.4% | -49.6% |
AVBP Cash And Cash Equivalents High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -8.0% | +303.4% | -52.6% | +6.4% |
| 5 y | 5-year | -8.0% | +303.4% | -52.6% | +6.4% |
| alltime | all time | -8.0% | +303.4% | -52.6% | +6.4% |
ArriVent BioPharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $150.39 M(-49.6%) |
| June 2024 | - | $298.67 M(-5.9%) |
| Mar 2024 | - | $317.39 M(+111.0%) |
| Dec 2023 | $150.39 M | $150.39 M(+6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2023 | - | $141.36 M(-10.4%) |
| June 2023 | - | $157.83 M(-3.4%) |
| Dec 2022 | $163.37 M(+338.2%) | - |
| Dec 2022 | - | $163.37 M |
| Dec 2021 | $37.28 M | - |
FAQ
- What is ArriVent BioPharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for ArriVent BioPharma?
- What is ArriVent BioPharma annual cash & cash equivalents year-on-year change?
- What is ArriVent BioPharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for ArriVent BioPharma?
- What is ArriVent BioPharma quarterly cash and cash equivalents year-on-year change?
What is ArriVent BioPharma annual cash & cash equivalents?
The current annual cash & cash equivalents of AVBP is $150.39 M
What is the all time high annual cash & cash equivalents for ArriVent BioPharma?
ArriVent BioPharma all-time high annual cash & cash equivalents is $163.37 M
What is ArriVent BioPharma annual cash & cash equivalents year-on-year change?
Over the past year, AVBP annual cash & cash equivalents has changed by -$12.98 M (-7.95%)
What is ArriVent BioPharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of AVBP is $150.39 M
What is the all time high quarterly cash and cash equivalents for ArriVent BioPharma?
ArriVent BioPharma all-time high quarterly cash and cash equivalents is $317.39 M
What is ArriVent BioPharma quarterly cash and cash equivalents year-on-year change?
Over the past year, AVBP quarterly cash and cash equivalents has changed by -$148.28 M (-49.65%)